Sarah Garner PhD, BPharm is currently Acting Programme Manager of the  Health Technologies and Pharmaceuticals Programme , Division of Health Systems and Public Health at WHO regional Office for Europe. Sarah is a pharmacist specializing in innovation, with previous work focusing on development strategies and the interface between Health Technology Assessment (HTA), regulation and payers. Sarah is an honorary professor at UCL and Manchester Universities. Her previous roles have included the Co-ordinator for the ‘Innovation, Access and Use’ Team in the Essential Medicines and Health Products Department at the World Health Organization ,the Associate Director for Science Policy and Research at the UK's National Institute for Health and Care Excellence (NICE) and Pharmacist Lead for the UK Government’s Special Advisory Committee on Antimicrobial Resistance. Sarah has led policy work-packages of public private research partnerships funded by the EU Innovative Medicines Initiative (GetReal, ADAPTSMART and Big Data for Better Outcomes) which are developing policy proposals for the adaptive pathways and use of real-word data in pharmaceutical development, regulatory and HTA decision making.  In 2010-11 Sarah was a Harkness Fellow in Healthcare Policy and Practice in the United States. Her research examined the impact of comparative effectiveness research and Health Technology Assessment on pharmaceutical and MedTech innovation. Sarah is working with the multi-stakeholder New Drug Development Paradigms (NEWDIGS) team at Massachusetts Institute of Technology and is a Fellow at the Centre for the Advancement of Sustainable Medical Innovation which is a collaboration between Oxford University and University College London.